Literature DB >> 30586530

Alcohol Use in Patients with Chronic Liver Disease.

Daniel Fuster1, Jeffrey H Samet2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30586530     DOI： 10.1056/NEJMc1814129

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Hepatic injury and inflammation alter ethanol metabolism and drinking behavior.

Authors:  Tianyi Ren; Bryan Mackowiak; Yuhong Lin; Yanhang Gao; Junqi Niu; Bin Gao
Journal:  Food Chem Toxicol       Date:  2019-12-21       Impact factor: 6.023

2.  The Gastroenterologist's Guide to Preventive Management of Compensated Cirrhosis.

Authors:  Akshay Shetty; Jung Jun Yum; Sammy Saab
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-08

Review 3.  Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease.

Authors:  Rachel L Bachrach; Shari S Rogal
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-05-23

Review 4.  Microbiota reprogramming for treatment of alcohol-related liver disease.

Authors:  Mohamed Tausif Siddiqui; Gail A M Cresci
Journal:  Transl Res       Date:  2020-07-17       Impact factor: 7.012

5.  Salvianic acid A alleviates chronic alcoholic liver disease by inhibiting HMGB1 translocation via down-regulating BRD4.

Authors:  Yanwen Lan; Ran Yan; Wen Shan; Junyi Chu; Ruimin Sun; Ruiwen Wang; Yan Zhao; Zhanyu Wang; Ning Zhang; Jihong Yao
Journal:  J Cell Mol Med       Date:  2020-06-29       Impact factor: 5.310

6.  SIRT2-mediated deacetylation and deubiquitination of C/EBPβ prevents ethanol-induced liver injury.

Authors:  Yingting Zhang; Xidai Long; Xin Ruan; Qian Wei; Lin Zhang; Lulu Wo; Dongdong Huang; Longshuai Lin; Difei Wang; Li Xia; Qinghua Zhao; Junling Liu; Qian Zhao; Ming He
Journal:  Cell Discov       Date:  2021-10-12       Impact factor: 10.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.